Outpatient Therapy with Gemcitabine and Docetaxel for Gallbladder, Biliary, and Cholangio-Carcinomas
- 1 August 2002
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Investigational New Drugs
- Vol. 20 (3), 351-356
- https://doi.org/10.1023/a:1016209901417
Abstract
Purpose. The prognosis of patients withbiliary tree carcinomas is very poor. Thediagnosis often occurs at an advancedstage, when curative resection is notpossible. We combined gemcitabine...Keywords
This publication has 17 references indexed in Scilit:
- Taxanes in combined modality therapy for solid tumorsCritical Reviews in Oncology/Hematology, 2001
- Phase II trial of gemcitabine, epirubicin and granulocyte colony-stimulating factor in patients with advanced pancreatic adenocarcinomaBritish Journal of Cancer, 1999
- Docetaxel (Taxotere) and gemcitabine in combination therapy.1999
- Two Consecutive Phase II Studies of 5-Fluorouracil/Leucovorin/Mitomycin C and of Gemcitabine in Patients with Advanced Biliary CancerOncology, 1999
- Gemcitabine: A pharmacologic and clinical overviewCancer Nursing, 1999
- Phase II Trial of Docetaxel for CholangiocarcinomaAmerican Journal of Clinical Oncology, 1999
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnnals Of Oncology, 1996
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal Of Cancer, 1995
- Malignancies of the biliary treeCurrent Problems in Surgery, 1995
- Surgical treatment of cholangiocarcinomaPublished by Springer Science and Business Media LLC ,1994